CalciMedica, Inc. (CALI): Market Value
CalciMedica, Inc. (CALI) relies on its authority in developing CRAC inhibitors to combat sepsis, while the patent protection of unique molecules ensures financial stability in the treatment of chronic inflammation. This price trend chart captures the indicator at 0.00. Local growth is driven by interim test results, although final approval catalysts and R&D risks continue to determine the market value.
Comprehensive metric breakdowns and analytics for CalciMedica (CALI)
- current price and projected stock value:
- stock exchange capitalization data:
- book value of equity indicators:
- business debt structure and liquidity details:
Total Debt to Capital CalciMedica, Inc.|CALI - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital CalciMedica Inc|CALI - Company Aggregate Debts|Debt to Book Capitalization Ratio CalciMedica Inc|CALI - Company Long-Term Loans and Borrowings|Company Short-Term Debt CalciMedica|Quick Ratio calcimedica.com
- financial results and valuation multiples details:
CALI - Net Profit|Future Profit CalciMedica, Inc.|CALI - Company Value to Net Income|Forward P/E Multiple calcimedica.com|CALI - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CalciMedica Inc|CALI - Operating profit before deduction of amortization|Earnings per share for the last twelve months CalciMedica|CALI - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months calcimedica.com|CALI - Earnings growth in current year|Net earnings per share growth forecast for next year CalciMedica, Inc.
- sales volume and revenue indicators:
Fundamental company analysis:CALI (CalciMedica)
Investors are seeking fundamental support in the business scale of CalciMedica, Inc. (CALI). CalciMedica, Inc. (CALI) automates the discovery of drugs for immune pathologies using AI models and robotic systems. This valuation chart visualizes the product of the current share price and the total number of shares. This metric determines the aggregate market value of the asset and its attractiveness to large institutional funds. Growth in this indicator confirms financial stability and reduces investment risks.
Key competitors
Market Value Argenx ARGX|BNTX: Market Capitalization|ABVX: Market Valuation|ADMA Biologics (ADMA) - Market Valuation|PTGX (Protagonist Therapeutics Inc) - Market Valuation|IMVT: Market Value|Market Value Kiniksa|Grifols Group - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Therapeutics) - Market Value|Market Capitalization AUPH (auriniapharma.com)|Market Capitalization BioCryst Pharmaceuticals, Inc. BCRX|VERA - Market Value|Market Value DNTH (Dianthus Corp)|pharvaris.com (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc|TRML (tourmalinebio.com) - Market Capitalization|Market Capitalization Intrexon|Market Valuation PHAR (Pharming)|NKTR (Nektar) - Market Value|Market Value upstreambio.com UPB|Market Capitalization zenasbio.com (ZBIO)|IMNM - Market Value|Gossamer Bio Inc (GOSS) - Market Valuation|KalVista Corp (KALV) - Market Value|Market Valuation Septerna Inc|Market Valuation PVLA|Market Capitalization savarapharma.com|Market Value Rigel Pharmaceuticals Inc (RIGL)|AnaptysBio - Market Capitalization|Market Capitalization ATXS (astriatx.com)|enGene Bio (ENGN) - Market Value|RAPT - Market Value|JBIO - Market Capitalization|ACRS: Market Capitalization|Market Value Kyverna (KYTX)|Market Valuation TLSA|Market Value CABA|Market Valuation VTYX (Ventyx Bio)|THTX (Theratechnologies Inc.) - Market Value|Market Value Avalo Therapeutics Inc AVTX|Eledon Pharmaceuticals Inc. (ELDN) - Market Value|AGEN - Market Value|Market Value CLYM (Climb Bio, Inc.)|ZURA: Market Capitalization|aTyr Pharma, Inc. - Market Value|ADAG (Adagene Corp) - Market Capitalization|ikenaoncology.com (IMA) - Market Capitalization|Market Valuation STTK (Shattuck Labs Inc)|Market Capitalization Equillium Inc|Market Capitalization CNTB (connectbiopharm.com)|IMUX: Market Capitalization|Atara Bio - Market Capitalization|IFRX: Market Value|XFOR: Market Capitalization|Market Valuation Adicet Bio Inc.|Market Value Celularity|Market Capitalization INMB (INmune Bio, Inc.)|Market Valuation BRNS (Barinthus Biotherapeutics)|KZR - Market Value|SAB Biotherapeutics Inc. - Market Valuation|Market Value AKTX (Akari Therapeutics plc)|ENLV: Market Valuation|Market Valuation QTTB|GOVX: Market Capitalization|Market Valuation Edesa|Market Value iBio Corporation|Carisma Therapeutics (CARM) - Market Capitalization|Market Capitalization XTLB|Market Valuation Bolt Biotherapeutics Inc. BOLT|Market Capitalization HCWB (HCW Biologics Inc.)|Market Capitalization Aptevo Therapeutics APVO|AIM - Market Value|ADTX - Market Capitalization|GRI: Market Capitalization|Market Valuation XORTX Therapeutics|Market Value Vyome Holdings Inc|REVB: Market Value|Market Capitalization INDP|Market Valuation BiondVax Pharmaceuticals SCNI|Market Capitalization AFMD (Affimed NV)|ALLK - Market Valuation|HOOKIPA Pharma Inc. - Market Capitalization|Market Value IGMS (igmbio.com)|iTeos Pharma (ITOS) - Market Value|Ocean Bio - Market Value|TCBP (TC BioPharm (Holdings) Plc) - Market Capitalization|Market Capitalization Third Harmonic Bio, Inc.
